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Abstract
To limit the use of antimicrobials in dairy cattle, farmers are increasingly encouraged to adopt
targeted treatment decisions based on knowledge of the pathogens causing clinical mastitis
(CM), whereby treatment of non-severe CM is generally recommended for gram-positive
mastitis but not for gram-negative or culture-negative mastitis. The objectives of this study
were to conduct a laboratory-based evaluation of the performance of a simplified slide test
as a tool to differentiate gram-positive CM from other cases of CM, and to compare its per-
formance against a commercially available on-farm test that is commonly used in our area
(VétoRapid). Test outcomes after 24–48 h incubation were compared to results from bacterio-
logical culture and matrix-assisted laser desorption/ionization time-of-flight mass spectrom-
etry (MALDI-ToF MS). Milk samples (n = 156) were obtained from cases of severe and
non-severe CM on seven farms and collected by farm personnel. After removal of small num-
bers of contaminated samples and organisms with unknown species identity, the simplified
slide test showed high sensitivity and accuracy (>80%), similar to the comparator test. For
most outcomes of interest (culture positive, Escherichia coli, or gram-positive growth), the spe-
cificity of the slide test was higher than the specificity of the comparator test. When consider-
ing non-severe cases of CM only, and interpreting detection of gram-positive organisms as
indicative of the need for antimicrobial treatment, the simplified test had higher specificity
(77.4% v. 60.4%) and higher positive predictive value (79.7% v. 70.0%) than the comparator
test and similar sensitivity (83.9% v. 87.5%). The proportion of sampled CM cases, contami-
nated samples and gram-positive mastitis cases – which affects the positive and negative pre-
dictive value, the economic value of diagnostic testing and its potential to reduce antimicrobial
use – differed between farms. The simplicity and accuracy of the slide test could make it an
attractive tool for farmers to target antimicrobial treatment of non-severe clinical mastitis.
Mastitis control is the most frequent reason for antibiotic use in lactating and non-lactating
dairy cows (Pol and Ruegg, 2007). Because of concerns that antibiotic usage may lead to anti-
microbial resistance (WHO, 2015), strategies are needed to promote and ensure prudent use of
antimicrobials for mastitis control. Selective treatment for CM in lactating cows, based on dif-
ferentiation between gram-positive pathogens and other causes of mastitis, has the potential to
reduce antibiotic use significantly without negative impact on udder health, production or cul-
ling (Lago et al., 2011a, 2011b; Mansion-de Vries et al., 2014). This has led to development of
an array of diagnostic tools for on-farm classification of mastitis pathogens to support selective
treatment.
Numerous culture-based detection kits for classification of mastitis pathogens have been
reviewed, and new tests are becoming commercially available (Malcata et al., 2020). There
are diagnostic tests based on Petrifilm, agar plates, or tube-test based systems. Some identify
bacteria as gram-positive or gram-negative, whereas other tests identify bacteria to genus or
species-level (Malcata et al., 2020). Some assays also include antibiotic susceptibility testing
(Jones et al., 2019). All tests are more reliable when used for diagnosis of broad categories,
such as growth, gram-positive and gram-negative species, rather than at genus or species
level (Lago and Godden, 2018). The performance of diagnostic assays can be evaluated
using scientific characteristics such as sensitivity, specificity and accuracy, and convenience
aspects such as cost, ease of use and turn-around time. For example, most Petrifilm or agar-
based tests are cheap but require considerable user training whereas Mastatest (Jones et al.,
2019) costs more but provides automated reading to increase ease of use.
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Although many tests were designed to identify pathogens to
genus or species level, farmers are more interested in advice on
antibiotic use than identification of causative agents of CM
(Griffioen et al., 2016). A simplified test to differentiate gram-
positive organisms from other causes of mastitis could be suffi-
cient to decide whether antimicrobial treatment of non-severe
CM is needed. In a different context, namely bacteriuria in
pregnant women, a similar need for reliable and simple testing
to differentiate gram-positive, gram-negative and culture-
negatives samples led to development of the Uricult dip-slide
(Van Dorsten and Bannister, 1986). The dip-slide is a plastic pad-
dle with two selective media that can be dipped in a liquid sample
such as urine or milk, allowing for growth of either gram-positive
or gram-negative organisms.
The aim of our study was to evaluate the laboratory perform-
ance of a simplified slide test for bovine mastitis, to determine
whether it differentiates gram-positive from other forms of mas-
titis with similar accuracy as a commercially available comparator
test commonly used in our practice.
Materials and methods
Regulatory compliance
This research was approved by the Ethics and Welfare Committee,
School of Veterinary Medicine, University of Glasgow, UK (Ref
50a/16).
Sample collection
Seven dairy farms in Scotland were selected based on herd size,
location, and willingness to cooperate in the study (online
Supplementary Table S1). Farm staff, including milkers and
herd managers, were trained to identify CM and to classify
cases as mild (abnormal milk, e.g. clots, flakes or serous milk),
moderate (abnormal milk and signs of udder inflammation: hard-
ness, swelling, redness, heat or pain) or severe (presence of add-
itional systemic signs of disease, e.g. fever, tachycardia,
tachypnoea, dehydration, or anorexia) (Pinzón-Sánchez and
Ruegg, 2011). They were taught how to collect milk samples asep-
tically according to National Mastitis Council recommendations
(NMC, 2017). CM cases were sampled regardless of mastitis
severity. If multiple quarters of a cow were affected simultan-
eously, each affected quarter was sampled. Any CM episode in
a quarter occurring >14 d after the previous episode, or caused
by a different aetiological agent, was considered a new CM case.
Animals were eligible for inclusion in the first week after calving
but no animals included were within 14 d of administration of
antimicrobial products.
Samples were collected from January to May 2018. They were
stored on farm at −20°C, and transported once a week to Glasgow
University’s Veterinary Diagnostic Services laboratory where they
were stored at −20°C until processing. All samples were cultured
within 4 weeks from CM detection.
Reference test
Samples were thawed at ambient temperature for up to 8 h and
processed simultaneously using the reference test, the simplified
slide test, and the commercially available plate-based comparator
test as described in the following two sections. For consistency, all
media were inoculated and read by the first author, starting with
the slide test. Bacteriological culture (NMC, 2017) with subse-
quent determination of species identity using MALDI-ToF MS
was used as the reference test as detailed in the supplementary file.
Slide test
Media of the simplified slide test (VétoSlide, Vétoquinol, Lure,
France) were inoculated by applying milk directly to each side
using cotton wool swabs (approximate volume 0.1 ml) to moisten
the entire surface of the media, as per manufacturer’s instructions.
The inoculated slides were incubated aerobically at 37°C and
examined after 24–48 h. When at least one colony was visible,
the sample was considered positive (Dohoo et al., 2011). Based
on the manufacturer’s guidelines, any growth on the green
media was considered to indicate presence of gram-negative bac-
teria and red colonies on the green media were considered
Escherichia coli. Growth on the red media was considered to indi-
cate presence of gram-positive bacteria (online Supplementary
Figure S1). When there was growth on both media, it was consid-
ered to indicate mixed infection with gram-positive and gram-
negative bacteria. Guidelines to identify contaminated samples
were not given, so samples were never classed as contaminated
based on the slide test.
Comparator test
Plates for the comparator test (VétoRapid, Vétoquinol, Lure,
France) were chosen for benchmarking because it is the most
commonly used on-farm test in the dairy community of the
authors and was previously evaluated in similar study settings
(Viora et al., 2014). These plates were inoculated with 0.01 ml
of milk per sector using disposable sterile calibrated plastic
loops, incubated aerobically at 37°C and examined after 24–48
h, as detailed in the supplementary file. Results were summarized
as gram-positive, gram-negative, E. coli and no growth for com-
parison with the reference and slide tests results. Samples not
yielding visible colonies on the comparator test were considered
negative for mastitis-associated pathogens. As for the slide test,
a contaminated category was not specified by the manufacturer.
Data analysis
Samples that were contaminated or contained non-identifiable
isolates by MALDI-ToF MS were excluded from evaluation of
diagnostic test performance. All other culture-positive and
culture-negative samples (n = 130) were used to calculate sensitiv-
ity, specificity, accuracy, positive predictive values (PPV) and
negative predictive values (NPV) for growth, gram-positives,
gram-negatives and E. coli. The reference test was used to classify
results from the slide test and comparator test as correct or incor-
rect. To evaluate the potential of the test kits as treatment decision
support tools, the calculations were repeated using a subset of the
130 samples, namely those from non-severe CM cases (n = 109),
and the outcome was expressed as ‘treatment’. This outcome is
equivalent to gram-positive growth or no gram-positive growth.
The latter category includes gram-negative bacteria, non-bacterial
growth, and culture-negative results.
Statistical analysis was performed in Excel (Microsoft Corp.,
Redmond, USA) using tabular methods, and in R. If the 95% con-
fidence interval for the difference between tests excluded zero, test
performance was considered significantly different. Full details are
provided in the supplementary file.
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Results
Reference test
Between 5 and 58 samples were collected from each farm (online
Supplementary Table S1). Of 156 samples, 23 (14.7%) were con-
taminated. Among 133 non-contaminated samples, 14 (10.5%)
showed no growth, and 116 (87.2%) showed growth of one or
two colony types that could be identified by the reference method
(Table 1). Three samples with growth of organisms that could not
be identified by the reference method were excluded from further
analysis. Within each farm’s sample set, gram-positive and gram-
negative isolates were identified, with a preponderance of
gram-positive results for some farms (Farms 3, 4 and 5), mostly
gram-negative results for others (Farms 2 and 6) and an even bal-
ance for the remainder (Farms 1 and 7; Figure 1). The proportion
of contaminated samples per farm ranged from 0 to 33%, indicat-
ing considerable differences in sample quality. The most common
species were E. coli and Streptococcus uberis, followed by other
major mastitis pathogens, including Streptococcus dysgalactiae,
Staphylococcus aureus and Klebsiella spp. (Table 1).
Slide test
After excluding contaminated samples and those with unidenti-
fied organisms, 130 samples were used to evaluate the perform-
ance of the slide test. A milk sample could be culture negative
or culture positive, contain a single colony type or two colony
types (two gram- positive morphotypes, two gram-negative mor-
photypes, or mixed gram-positive and gram-negative growth).
The latter were considered gram-positive in the gram-positive
analysis and gram-negative in the gram-negative analysis. The
proportion of culture negative results was considerably higher
for the slide test (20%) than for the reference test (10.8%). Of
26 culture-negative samples in the slide test, 12 (46.2%) were cor-
rectly classified. Of 14 false negative slide test results, seven were
Table 1. Test results of 130 milk samples from bovine clinical mastitis based on a reference test consisting of standard bacteriological culture and species
identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-ToF MS) in comparison with the simplified slide test under
evaluation (VétoSlide, Vétoquinol, Lure, France) and a commercially available plate-based comparator (VétoRapid, Vétoquinol, Lure, France)
Result Reference numbera (%) VétoSlide numbera (%) VétoRapid numbera (%)
No growth 14 (10.8) 26 (20.0) 17 (13.1)
Growth 116 (89.2) 104 (80.0) 113 (86.9)
Gram-positive only 54 (41.5) 50 (38.5) 55 (42.3)
Gram-negative only 53 (40.8) 38 (29.2) 30 (23.1)
Mixed (Gram-positive and Gram-negative) 7 (5.4) 16 (12.3) 28 (21.5)
Gram-negative 60 (46.2) 54 (41.5) 58 (44.6)
Escherichia coli 51 (39.2) 45 (34.6) 50 (38.5)
Klebsiella spp. 6 (4.6) n/a 16 (12.3)
Other gram-negative 4 (2.8) n/a 2 (1.5)
Gram-positive 61 (46.9) 66 (50.8) 83 (63.8)
Staphylococcus spp. 21 (16.2) n/a 56 (43.1)
Staphylococcus aureus 7 (5.4) n/a 43 (33.1)
Non-aureus staphylococci 15 (11.5) n/a 21 (16.2)
Streptococcus spp. 32 (24.6) n/a 50 (38.5)
Streptococcus dysgalactiae 10 (7.7) n/a 11 (8.5)
Streptococcus uberis 21 (16.2) n/a 38 (29.2)
Other Streptococcus spp. 1 (0.8) n/a 6 (4.6)
Enterococcus spp. 3 (2.3) n/a 2 (1.5)
Other gram-positive 13 (10.0) n/a 1 (0.8)
Prototheca zopfii 2 (1.5) n/a n/a
n/a, not applicable.
aThe total number of species/genera listed exceeds the number of samples because more than one species/genus was detected in some samples that were not contaminated based on the
NMC standard definition of 3 or more colony types (the percentage shown is related to the proportion of samples).
Fig. 1. Sampling results for bovine milk samples (n = 130) from quarters with clinical
mastitis by participating farm. The number of samples for each farm were, from farm
1 to 7 respectively, 58, 30, 35, 5, 8, 12 and 10.
Journal of Dairy Research 3
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0022029921000303
Downloaded from https://www.cambridge.org/core. University of Glasgow Library, on 10 May 2021 at 14:07:04, subject to the Cambridge Core terms of use, available at
from samples with gram-positive growth in the reference test and
seven from samples with gram-negative growth.
Mixed gram-positive and gram-negative growth was more com-
mon in the slide test (12.3%) than in the reference test (5.4%)
(Table 1). The sensitivity of the slide test was similar for gram-
positive and gram-negative organisms, but specificity was higher
for the latter, resulting in higher accuracy for gram-negative organ-
isms (89.2%) or E. coli (92.3%) than for gram-positive organisms
(79.2%: Table 2). For the samples from non-severe CM (n = 109),
the potential of the slide test to be used as treatment decision sup-
port tool was evaluated. Sensitivity and specificity for this subset
were similar to those for all CM cases (Table 2).
Mean PPV of the slide test was high (between 92.6 and 98.1%)
for growth, gram-negative results, and E. coli and moderate
(between 75 and 80%) for gram-positive results (all based on
130 samples) and treatment (based on 109 samples). The mean
NPV was less than 50% for growth and between 82 and 90.6%
for all other outcomes (Table 2).
Benchmarking against the comparator test
Despite using a higher inoculum, the slide test gave fewer false
positive results for growth than the comparator test, resulting in
significantly higher specificity. Low specificity of the comparator
Table 2. Performance of the simplified slide test under evaluation (VétoSlide, Vétoquinol, Lure, France) and a commercially available plate-based comparator
(VétoRapid, Vétoquinol, Lure, France) for identification of mastitis pathogens (n = 130 samples) and as a treatment decision support tools for non-severe clinical
mastitis (n = 109 samples)
VétoSlide VétoRapid Difference
Sensitivity
Growth 87.9 [80.8; 92.7] 92.2 [85.9; 95.9] 4.3 [−2.2; 10.8]
Gram-negative 83.3 [72.0; 90.7] 83.3 [72.0; 90.7] 0.0 [−9.2; 9.2]
Gram-positive (n = 61) 82.0 [70.5; 89.6] 88.5 [78.2; 94.3] 6.6 [−3.5; 16.6]
E. coli (n = 51) 84.3 [72.0; 91.8] 86.3 [74.3; 93.2] 2.0 [−9.6; 13.5]
Treatment (n = 56) 83.9 [72.2; 91.3] 87.5 [76.4; 93.8] 3.6 [−6.3; 13.4]
Specificity
Growth 85.7 [60.1; 96.0] 57.1 [32.6; 78.6] −28.6 [−52.2; −4.9]*
Gram-negative 94.3 [86.2; 97.8] 88.6 [79.0; 94.1] −5.7 [−13.5; 2.1]
Gram-positive 76.8 [65.6; 85.2] 58.0 [46.2; 68.9] −18.2 [−30.4; −7.3]*
E. coli 97.5 [91.2; 99.3] 92.4 [84.4; 96.5] −5.1 [−9.9; −0.2]*
Treatment 77.4 [64.5; 86.5] 60.4 [46.9; 72.4] −17 [−30.6; −3.4]*
Accuracy
Growth 87.7 [80.9; 92.3] 88.5 [81.8; 92.9] 0.8 [−5.8; 7.3]
Gram-negative 89.2 [82.7; 93.5] 86.2 [79.2; 91.1] −3.1 [−9.1; 2.9]
Gram-positive 79.2 [71.5; 85.3] 72.3 [64.1; 79.3] −6.9 [−15; 1.1]
E. coli 92.3 [86.4; 95.8] 90.0 [83.6; 94.1] −2.3 [−7.7; 3.1]
Treatment 80.7 [72.3; 87.0] 74.3 [65.4; 81.6] −6.4 [−15; 2.1]
Positive predictive value
Growth 98.1 [93.3; 99.5] 94.7 [88.9; 97.5] −3.4 [−6.7; −0.03]*
Gram-negative 92.6 [82.4; 97.1] 86.2 [75.1; 92.8] −6.4 [−15.2; 2.4]
Gram-positive 75.8 [64.2; 84.5] 65.1 [54.3; 74.4] −10.7 [−18.9; −2.55]*
E. coli 95.6 [85.2; 98.8] 88.0 [76.2; 94.4] −7.6 [−14.8; −0.3]*
Treatment 79.7 [67.7; 88.0] 70.0 [58.5; 79.5] −9.7 [−18.5; −0.86]*
Negative predictive value
Growth 46.2 [28.8; 64.5] 47.1 [26.2; 69.0] 0.9 [−18.7; 20.5]
Gram-negative 86.8 [77.4; 92.7] 86.1 [76.3; 92.3] −0.7 [−7.3; 5.8]
Gram-positive 82.8 [71.8; 90.1] 85.1 [72.3; 92.6] 2.3[−7.3; 11.9]
E. coli 90.6 [82.5; 95.2] 91.3 [83.0; 95.7] 0.7 [−5.8; 7.2]
Treatment 82.0 [69.2; 90.2] 82.1 [67.3; 91.0] 0.1 [−10.7; 10.8]
*Outcomes where VétoSlide and VétoRapid are significantly different.
The total of samples that yield in the reference test growth, Gram-negative, Gram-positive, E. coli and Treatment were, 116, 60, 61, 51 and 56 respectively.
Results are based on comparison with a reference test consisting of culture and species identification based on matrix-assisted laser-desorption ionization time-of-flight mass spectrometry
and the difference compares the two tests while correcting for dependence. Values are point estimates expressed as percentages, with 95% confidence intervals in brackets.
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test was partly due to moderate specificity in the detection of
Staph. aureus and Strep. uberis (70.7 and 82.6%, respectively;
online Supplementary Table S2), which was accompanied by
high sensitivity for the same pathogens (100 and 90.5%, respect-
ively). For sensitivity, there were no statistically significant differ-
ences among tests for any of the outcomes (Table 2). Despite the
greater specificity of the slide test, overall accuracy of the two tests
was not significantly different. In our study population, the slide
test had significantly greater PPV than the comparator test for
growth, gram-positive, E. coli and treatment, whereas their
NPVs were similar for all outcomes.
Discussion
We evaluated the laboratory performance of a simplified culture-
based slide test, VétoSlide, which was developed as a potential
point-of-care tool to support farmers’ CM treatment decisions.
Its accuracy for gram-positive organisms in samples from non-
severe CM (80.7%) is in the same range as commercially available
point-of-care tests, including the comparator test (VétoRapid)
(74.3%, this study), the Minnesota Easy Culture System-Triplate
(81.3%) (Ferreira et al., 2018), Minnesota Easy Culture
System-biplate (81 to 84%) (Royster et al., 2014), Petrifilm
(80.2%) (Mansion-de Vries et al., 2014) and MastDecide (58.6
to 85.3%) (Leimbach and Krömker, 2018), although comparisons
between studies are complicated by differences in study design,
populations, and methods of analysis. Such differences make
comparison of predictive values problematic because they are
highly dependent on pathogen prevalence, which is farm-specific.
Benchmarking of the new slide test against a commercially avail-
able comparator in a single study allowed us to compare predict-
ive values, which are more important in practice than sensitivity,
specificity, or accuracy. A high PPV means that unnecessary treat-
ment is minimized whereas a high NPV means that treatment is
withheld only when cows truly do not need it. The slide test out-
performed the comparator test in PPV and had similar NPV,
meaning that the reduced risk of over-treating was not accompan-
ied by an increased risk of under-treating. Whether positive or
negative predictive value is considered more important in inform-
ing treatment decisions differs between regions. In some areas,
such as southern Europe, it is generally assumed that antimicro-
bial treatment of mastitis is needed until proven otherwise
(Busani et al., 2004). Conversely, in northern Europe, it is
assumed that treatment is not needed until proven otherwise
(Persson Waller et al., 2016). Within countries, this balance
may shift over time, as illustrated by work from The
Netherlands on selective dry cow treatment (DCT). Two
split-udder trials conducted two decades apart (Schukken et al.,
1993; Scherpenzeel et al., 2014) in the same country both showed
that blanket DCT prevents CM when compared to selective DCT.
However, the first study concluded that blanket DCT should be
used to prevent CM despite the need to ‘eliminate unnecessary
use of antibiotics’, whereas the second study emphasized the
reduction in antimicrobial use that could be achieved by abandon-
ing blanket DCT.
Whether the price of the diagnostic test is worth paying in
terms of financial benefit is a matter of debate. On farms with a
single dominant pathogen, the value of information may be lim-
ited (Cha et al., 2016), but our data showed that several farms did
not have clear predominance of gram-positive or gram-negative
mastitis over other types of mastitis. Some authors argue that
even with just 20% of gram-positive mastitis, use of on-farm
diagnostics would not be cost-effective (Down et al., 2017).
Hence, the value of information would be farm-specific and no
blanket statements around cost-benefit or reductions in anti-
microbial use can be made based on our results. It is clear, how-
ever, that some farms will need further training in sample
collection and handling to reduce the number of contaminated
samples and to make investment of time and money into diagnos-
tic testing better value for money. Moreover, before uptake of the
slide test can be recommended on-farm, evaluation under
on-farm conditions will be needed, as our laboratory-based ana-
lysis included freezing and thawing of milk, which would not
be part of its on-farm use. Reading of plates at 24 and 48 h, as
done here to allow for comparison with VétoRapid results,
would cause considerable delay in treatment decisions, and
shorter incubation times would need to be considered, with
growth of gram-negative organisms often visible well within 24
h (data not shown).
The reference test used in our study included species identifi-
cation by MALDI-ToF MS and revealed the presence of several
species that are not recognized as typical mastitis pathogens, e.g.
Bacillus and Lysinibacillus species. Although both genera are
gram-positive, it is debatable whether they should be targeted
with antimicrobial treatment because little is known about their
role as pathogenic agents or their response to treatment. None
of the currently available point-of-care tests for mastitis have
the ability to differentiate such organisms from recognized mas-
titis pathogens. When information at species or subspecies level
is required for advanced investigations or decision making at
herd or animal level, laboratory-based microbial diagnostics con-
tinue to be important (Mansion-de Vries et al., 2014). For
on-farm treatment decision making, however, the simplified
slide test appears to have the potential to be an affordable, accur-
ate, and user-friendly option.
In conclusion, using laboratory-based evaluation of farmer col-
lected milk samples we demonstrated that a simplified slide test
performs similar to the commercially available on-farm test that
was used for benchmarking in terms of sensitivity or accuracy,
whilst performing better in terms of specificity. The simplicity
of the slide test can make it an attractive tool for farmers to target
antimicrobial treatment of non-severe CM cases caused by gram-
positive organisms with good diagnostic accuracy. Further evalu-
ation of user-friendliness and test accuracy in on-farm settings is
needed, followed by assessment of uptake, economic impact, and
reduction in antimicrobial use. In addition, users’ willingness and
ability to collect high quality milk samples needs to be understood
and supported.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0022029921000303
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